Rapid evidence synthesis on SARS-CoV-2 emergent strains and UK-approved vaccines, originally shared with Improvement Analytics Unit, and for further circulation with NHSE/I and other groups in technical advisory/public education
Rapid evidence synthesis on SARS-CoV-2 emergent strains and UK-approved vaccines, originally shared with Improvement Analytics Unit, and for further circulation with NHSE/I and other groups in technical advisory/public education
MIT License